Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
21.14
+0.10 (0.48%)
Nov 13, 2026, 4:00 PM EST - Market closed
Tectonic Therapeutic Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 234.67 | 253.8 | 141.24 | 28.77 | 35.97 | 28.06 |
Cash & Short-Term Investments | 234.67 | 253.8 | 141.24 | 28.77 | 35.97 | 28.06 |
Cash Growth | -12.58% | 79.69% | 390.94% | -20.01% | 28.16% | 88435.19% |
Prepaid Expenses | 3.89 | 2.97 | 5.62 | 2.12 | 1.08 | 0.56 |
Restricted Cash | - | 0.59 | - | - | - | - |
Total Current Assets | 238.55 | 257.36 | 146.86 | 30.88 | 37.04 | 28.62 |
Property, Plant & Equipment | 4.25 | 2.55 | 5.31 | 7.23 | 9.55 | 3.66 |
Long-Term Deferred Charges | - | - | - | 0.67 | - | - |
Other Long-Term Assets | 1.06 | 1.13 | 0.74 | 0.62 | 0.61 | 0.6 |
Total Assets | 243.86 | 261.04 | 152.91 | 39.4 | 47.21 | 32.88 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.62 | 1.09 | 0.98 | 0.41 | 0.57 | 1.81 |
Accrued Expenses | 8.99 | 7.34 | 7.85 | 8.14 | 5.32 | 1.31 |
Current Portion of Leases | 1.49 | 1.23 | 2.78 | 1.82 | 1.45 | 0.36 |
Current Unearned Revenue | - | - | - | - | - | 0.01 |
Other Current Liabilities | - | - | - | 30.52 | 0.5 | 0.64 |
Total Current Liabilities | 12.1 | 9.67 | 11.61 | 40.89 | 7.84 | 4.12 |
Long-Term Leases | 2.43 | 0.04 | 0.52 | 2.52 | 4.34 | 0.7 |
Long-Term Unearned Revenue | - | - | - | - | - | 0.41 |
Other Long-Term Liabilities | - | - | - | - | 0.06 | - |
Total Liabilities | 14.54 | 9.71 | 12.13 | 43.41 | 12.24 | 5.23 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | - | - | - |
Additional Paid-In Capital | 520.93 | 474.16 | 289.35 | 5.98 | 2.13 | 0.64 |
Retained Earnings | -291.61 | -222.74 | -148.59 | -90.6 | -47.78 | -15.6 |
Comprehensive Income & Other | - | -0.1 | 0.01 | -0.01 | - | - |
Total Common Equity | 229.33 | 251.33 | 140.78 | -84.64 | -45.65 | -14.96 |
Shareholders' Equity | 229.33 | 251.33 | 140.78 | -4.01 | 34.97 | 27.65 |
Total Liabilities & Equity | 243.86 | 261.04 | 152.91 | 39.4 | 47.21 | 32.88 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3.92 | 1.28 | 3.3 | 4.34 | 5.79 | 1.06 |
Net Cash (Debt) | 230.75 | 252.52 | 137.94 | 24.43 | 30.17 | 27.01 |
Net Cash Growth | -13.64% | 83.07% | 464.71% | -19.05% | 11.72% | - |
Net Cash Per Share | 12.12 | 13.78 | 16.25 | 19.26 | 11.95 | - |
Filing Date Shares Outstanding | 19.95 | 18.78 | 18.66 | 2.63 | 2.53 | - |
Total Common Shares Outstanding | 19.94 | 18.74 | 14.86 | 2.63 | 2.53 | - |
Working Capital | 226.45 | 247.69 | 135.25 | -10 | 29.21 | 24.5 |
Book Value Per Share | 11.50 | 13.41 | 9.48 | -32.13 | -18.08 | - |
Tangible Book Value | 229.33 | 251.33 | 140.78 | -84.64 | -45.65 | -14.96 |
Tangible Book Value Per Share | 11.50 | 13.41 | 9.48 | -32.13 | -18.08 | - |
Machinery | - | 4.57 | 4.87 | 4.92 | 4.41 | 3.69 |
Construction In Progress | - | - | - | 0.04 | 0.05 | 0.34 |
Leasehold Improvements | - | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 |